Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).
Clinical trial NCT00430534 · COMPLETED
Trial details
- NCT number
- NCT00430534
- Sponsor
- Henogen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.